154 related articles for article (PubMed ID: 18976662)
1. Germline humanization of a non-human primate antibody that neutralizes the anthrax toxin, by in vitro and in silico engineering.
Pelat T; Bedouelle H; Rees AR; Crennell SJ; Lefranc MP; Thullier P
J Mol Biol; 2008 Dec; 384(5):1400-7. PubMed ID: 18976662
[TBL] [Abstract][Full Text] [Related]
2. A germline knowledge based computational approach for determining antibody complementarity determining regions.
Zhao S; Lu J
Mol Immunol; 2010 Jan; 47(4):694-700. PubMed ID: 19939452
[TBL] [Abstract][Full Text] [Related]
3. Human framework adaptation of a mouse anti-human IL-13 antibody.
Fransson J; Teplyakov A; Raghunathan G; Chi E; Cordier W; Dinh T; Feng Y; Giles-Komar J; Gilliland G; Lollo B; Malia TJ; Nishioka W; Obmolova G; Zhao S; Zhao Y; Swanson RV; Almagro JC
J Mol Biol; 2010 Apr; 398(2):214-31. PubMed ID: 20226193
[TBL] [Abstract][Full Text] [Related]
4. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
5. Stabilization and humanization of a single-chain Fv antibody fragment specific for human lymphocyte antigen CD19 by designed point mutations and CDR-grafting onto a human framework.
Kügler M; Stein C; Schwenkert M; Saul D; Vockentanz L; Huber T; Wetzel SK; Scholz O; Plückthun A; Honegger A; Fey GH
Protein Eng Des Sel; 2009 Mar; 22(3):135-47. PubMed ID: 19188138
[TBL] [Abstract][Full Text] [Related]
6. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
[TBL] [Abstract][Full Text] [Related]
7. Selection of human antibodies against cell surface-associated oligomeric anthrax protective antigen.
Steiniger SC; Altobell LJ; Zhou B; Janda KD
Mol Immunol; 2007 Apr; 44(10):2749-55. PubMed ID: 17210180
[TBL] [Abstract][Full Text] [Related]
8. Use of human germline genes in a CDR homology-based approach to antibody humanization.
Hwang WY; Almagro JC; Buss TN; Tan P; Foote J
Methods; 2005 May; 36(1):35-42. PubMed ID: 15848073
[TBL] [Abstract][Full Text] [Related]
9. A bioinformatics pipeline to build a knowledge database for in silico antibody engineering.
Zhao S; Lu J
Mol Immunol; 2011 Apr; 48(8):1019-26. PubMed ID: 21310488
[TBL] [Abstract][Full Text] [Related]
10. Functional humanization of an anti-CD30 Fab fragment for the immunotherapy of Hodgkin's lymphoma using an in vitro evolution approach.
Schlapschy M; Gruber H; Gresch O; Schäfer C; Renner C; Pfreundschuh M; Skerra A
Protein Eng Des Sel; 2004 Dec; 17(12):847-60. PubMed ID: 15708864
[TBL] [Abstract][Full Text] [Related]
11. Collagen type II is recognized by a pathogenic antibody through germline encoded structures.
Böiers U; Lanig H; Sehnert B; Holmdahl R; Burkhardt H
Eur J Immunol; 2008 Oct; 38(10):2784-95. PubMed ID: 18825755
[TBL] [Abstract][Full Text] [Related]
12. High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation.
Pelat T; Hust M; Laffly E; Condemine F; Bottex C; Vidal D; Lefranc MP; Dübel S; Thullier P
Antimicrob Agents Chemother; 2007 Aug; 51(8):2758-64. PubMed ID: 17517846
[TBL] [Abstract][Full Text] [Related]
13. Engineering antibodies for stability and efficient folding.
Honegger A
Handb Exp Pharmacol; 2008; (181):47-68. PubMed ID: 18071941
[TBL] [Abstract][Full Text] [Related]
14. SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity.
Gonzales NR; Padlan EA; De Pascalis R; Schuck P; Schlom J; Kashmiri SV
Mol Immunol; 2004 Jul; 41(9):863-72. PubMed ID: 15261458
[TBL] [Abstract][Full Text] [Related]
15. A molecular immunology approach to antibody humanization and functional optimization.
Lazar GA; Desjarlais JR; Jacinto J; Karki S; Hammond PW
Mol Immunol; 2007 Mar; 44(8):1986-98. PubMed ID: 17079018
[TBL] [Abstract][Full Text] [Related]
16. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier.
Boado RJ; Zhang Y; Zhang Y; Pardridge WM
Biotechnol Bioeng; 2007 Feb; 96(2):381-91. PubMed ID: 16937408
[TBL] [Abstract][Full Text] [Related]
17. Initial repertoire of anti-(4-hydroxy-3-nitrophenylacetyl) antibodies as potential donors for effective affinity maturation.
Furukawa K; Manabe A; Furukawa A; Kuba H; Okajima T; Azuma T
Mol Immunol; 2006 Apr; 43(11):1751-60. PubMed ID: 16406527
[TBL] [Abstract][Full Text] [Related]
18. Crystal structures of human antibodies: a detailed and unfinished tapestry of immunoglobulin gene products.
Ramsland PA; Farrugia W
J Mol Recognit; 2002; 15(5):248-59. PubMed ID: 12447901
[TBL] [Abstract][Full Text] [Related]
19. Human antibodies from immunized donors are protective against anthrax toxin in vivo.
Wild MA; Xin H; Maruyama T; Nolan MJ; Calveley PM; Malone JD; Wallace MR; Bowdish KS
Nat Biotechnol; 2003 Nov; 21(11):1305-6. PubMed ID: 14555959
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis.
Kaur M; Chug H; Singh H; Chandra S; Mishra M; Sharma M; Bhatnagar R
Mol Immunol; 2009 Jun; 46(10):2107-15. PubMed ID: 19356802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
